Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 4 of these applications claim priority to application 13/003,811, filed May 25, 2011. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 9,107,924 | Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors In force · High confidence | Pharmacyclics LLC | In force | High confidence | ||
| US 9,795,605 | Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors In force · High confidence | Pharmacyclics LLC | In force | High confidence | ||
| US 9,278,100 | Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors In force · Medium confidence | Pharmacyclics LLC | In force | Medium confidence | ||
| US 8,883,803 | Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors Grace period ended Nov 11, 2026 · lapse expected · Low confidence | Pharmacyclics LLC | Grace period ended Nov 11, 2026 lapse expected | Low confidence | ||
| Application 13/003,811 | Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors Abandoned Abandoned Dec 11, 2016 | Pharmacyclics LLC | Abandoned | Abandoned Dec 11, 2016 | ||
| Application 15/292,614 | Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors Abandoned Abandoned Mar 26, 2019 | Pharmacyclics LLC | Abandoned | Abandoned Mar 26, 2019 | ||
| Application 15/790,725 | Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors Abandoned Abandoned Mar 1, 2019 | Pharmacyclics LLC | Abandoned | Abandoned Mar 1, 2019 | ||
| Application 16/361,069 | Inhibitors of Bruton's Tyrosine Kinase for the Treatment of Solid Tumors Abandoned Abandoned Sep 11, 2021 | Pharmacyclics LLC | Abandoned | Abandoned Sep 11, 2021 |
8 of 8 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by Pharmacyclics, Inc..
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.